Fidelity Investments Portfolio holdings
Fidelity Investments, founded in 1946 by Edward C. Johnson II and headquartered in Boston, Massachusetts, is one of the largest privately-held financial services firms in the world, managing hundreds of billions in assets. Known for its wide array of investment products, including mutual funds, retirement accounts, brokerage services, and wealth management, Fidelity caters to both individual investors and institutions with a reputation for strong customer service and innovative tools like its active trader platforms. The company pioneered direct-to-investor mutual fund sales, bypassing traditional brokers, and has since expanded into areas like cryptocurrency trading and commission-free stock trades. Still family-controlled by the Johnson family, Fidelity blends a legacy of traditional investing with a forward-looking approach to technology and market trends.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$1.51B |
| 2 |
Microsoft
MSFT
|
+$1.13B |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$1.04B |
| 4 |
American Express
AXP
|
+$714M |
| 5 |
HCA Healthcare
HCA
|
+$675M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amgen
AMGN
|
+$6.87B |
| 2 |
Wells Fargo
WFC
|
+$6.1B |
| 3 |
Becton Dickinson
BDX
|
+$3.96B |
| 4 |
Tesla
TSLA
|
+$3.74B |
| 5 |
3M
MMM
|
+$1.33B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.87% |
| 2 | Financials | 15.4% |
| 3 | Healthcare | 15.27% |
| 4 | Consumer Discretionary | 11.41% |
| 5 | Communication Services | 10.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1626
Kimbell Royalty Partners
KRP
$1.48B
| $21.5M | ﹤0.01% |
1,095,426
+196,100
| +22% | +$4.31M |
|
1627
Twilio
TWLO
$36.6B
| $21.4M | ﹤0.01% |
248,440
-387,647
| -61% | -$28.3M |
|
1628
Ecolab
ECL
$79.9B
| $21.4M | ﹤0.01% |
136,631
-188,446
| -58% | -$27.9M |
|
1629
Viridian Therapeutics
VRDN
$2.67B
| $21.4M | ﹤0.01% |
255,872
-32,987
| -11% | -$3.11M |
|
1630
Vanguard FTSE Emerging Markets ETF
VWO
$124B
| $21.3M | ﹤0.01% |
519,584
+158,649
| +44% | +$6.67M |
|
|
Y
1631
DELISTED
Alleghany Corp
Y
| $21.3M | ﹤0.01% |
32,635
+25,998
| +392% | +$16.3M |
|
1632
Lincoln Electric
LECO
$15.4B
| $21.3M | ﹤0.01% |
227,653
-41,147
| -15% | -$3.81M |
|
1633
Liberty Media Series A
FWONA
$23.6B
| $21.2M | ﹤0.01% |
623,204
-684,744
| -52% | -$22.7M |
|
1634
Toro Company
TTC
$9.49B
| $21.2M | ﹤0.01% |
353,460
+4,334
| +1% | +$264K |
|
|
AYX
1635
DELISTED
Alteryx Inc
AYX
| $21.1M | ﹤0.01% |
369,100
+351,100
| +1,951% | +$17.9M |
|
|
TSE
1636
DELISTED
Trinseo
TSE
| $21.1M | ﹤0.01% |
269,278
-108,698
| -29% | -$8.14M |
|
1637
Karyopharm Therapeutics
KPTI
$48M
| $21.1M | ﹤0.01% |
82,519
-20,160
| -20% | -$5.57M |
|
1638
First Bancorp
FBP
$4.38B
| $21M | ﹤0.01% |
2,312,678
-5,545,600
| -71% | -$47M |
|
|
GHDX
1639
DELISTED
Genomic Health, Inc.
GHDX
| $21M | ﹤0.01% |
299,542
+166,681
| +125% | +$9.75M |
|
1640
Voya Financial
VOYA
$9.19B
| $21M | ﹤0.01% |
422,475
-460,998
| -52% | -$22.8M |
|
|
VVC
1641
DELISTED
Vectren Corporation
VVC
| $20.9M | ﹤0.01% |
293,038
-141
| -0% | -$10.1K |
|
|
RDUS
1642
DELISTED
Radius Health, Inc.
RDUS
| $20.8M | ﹤0.01% |
1,170,409
-1,295,224
| -53% | -$29.3M |
|
1643
Zions Bancorporation
ZION
$10.3B
| $20.8M | ﹤0.01% |
414,287
-19,541
| -5% | -$1.03M |
|
1644
Arthur J. Gallagher & Co
AJG
$63.6B
| $20.7M | ﹤0.01% |
278,583
-3,951
| -1% | -$283K |
|
|
PRNB
1645
DELISTED
Principia Biopharma Inc. Common Stock
PRNB
| $20.7M | ﹤0.01% |
+708,877
| New | +$20M |
|
|
S
1646
DELISTED
Sprint Corporation
S
| $20.7M | ﹤0.01% |
3,160,575
+111,400
| +4% | +$662K |
|
1647
Invesco Mortgage Capital
IVR
$805M
| $20.7M | ﹤0.01% |
130,636
-9,605
| -7% | -$1.55M |
|
|
PCH
1648
DELISTED
PotlatchDeltic
PCH
| $20.5M | ﹤0.01% |
501,252
-306,363
| -38% | -$14.5M |
|
1649
Installed Building Products
IBP
$6.49B
| $20.5M | ﹤0.01% |
525,991
+99,986
| +23% | +$5.04M |
|
1650
Ally Financial
ALLY
$13.3B
| $20.3M | ﹤0.01% |
767,957
-370,592
| -33% | -$10.1M |
|
Similar funds
Fidelity Investments's Q3 2018 Portfolio in Review
As of Q3 2018, Fidelity Investments held 3,957 positions worth $889B, up 2.3% from $869B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Fidelity Investments withdrew a net $33.9B in Q3 2018, closing 54 positions and reducing 1,318 holdings. Its most notable exit was Williams Partners L.P., an estimated $511M position sold in full.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 18% a quarter earlier, followed by Financials and Healthcare.
Against the trend, Fidelity Investments opened a new position in Rubius Therapeutics, Inc worth $141M.
- Fidelity Investments's largest Q3 2018 buy was Rubius Therapeutics, Inc: 6,226,764 shares worth $141M.
- Fidelity Investments added most to Apple in Q3 2018, an estimated $1.51B increase.
- Fidelity Investments's biggest Q3 2018 reduction was Amgen, cutting an estimated $6.87B.
- Fidelity Investments fully exited Williams Partners L.P. in Q3 2018, selling an estimated $511M.
- Fidelity Investments's ten largest holdings make up 22% of its $889B portfolio in Q3 2018.
- Fidelity Investments opened 1,284 new positions and closed 54 in Q3 2018.
- Fidelity Investments's portfolio value rose 2.3% quarter-over-quarter to $889B.
Based on Fidelity Investments's 13F filing for Q3 2018, filed 9 Nov 2018.